跳到主要內容區

M-H Hsu, S-M Hsu, Y-C Kuo, C-Y Liu, C-Y Hsieh, Y-C Twu, C-K Wang, Y-H Wang and Y-J Liao,Treatment with low-dose sorafenib in combination with a novel benzimidazole derivative bearing a pyrolidine side chain provides synergistic anti-proliferative effects against human liver cancer,RSC Advances,(SCI)

 (SCI)

 Treatment with low-dose sorafenib in combination with a novel benzimidazole derivative bearing a pyrolidine side chain provides synergistic anti-proliferative effects against human liver cancer

 RSC Advances

 M-H Hsu, S-M Hsu, Y-C Kuo, C-Y Liu, C-Y Hsieh, Y-C Twu, C-K Wang, Y-H Wang and Y-J Liao

 2020-10-28

瀏覽數: